RGEN - REPLIGEN CORP
This page shows which of the focused investors we track hold RGEN and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2026 it was held by 3 managers with an aggregate reported value of $190.74M, which is 0.02% of the combined portfolio.
As of Q1 2026, 3 tracked institutional managers held RGEN (REPLIGEN CORP) with an aggregate reported value of $190.74M — 0.02% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades RGEN — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2026
- Ticker
- RGEN
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Lee Ainslie - Maverick Capital | 2.08% | New | 1,518,805 | $178.95M |
| 2 | Wallace Weitz - Weitz Investment Management | 0.21% | New | 25,500 | $3M |
Other instruments
Bonds, warrants, or other non-share-class principal positions in RGEN.
| 1 | Howard Marks - Oaktree Capital Management | Reduce -8.5% | 8,997,000 | $8.79M |
Loading holder history for RGEN…